InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.71
(
0.42%
)
Bitcoin
64,178.99
(
-0.28%
)
Post# of 4856
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Japes1

Send PM Follow Ignore
Followers 0
Posts 25
Boards Moderated 0
Alias Born 06/22/2013

Japes1

Re: None

Thursday, 05/21/2015 1:25:10 PM

Thursday, May 21, 2015 1:25:10 PM

Post# of 4856
Yes, the company totally blew the PR. But I disagree re AF he was mentioning slamming CUR for months on Twitter feed. He mentioned he was waiting to put together a hit piece, and made disparaging remarks re the co and the science. The ill timed, poorly written article gave him the fuel.
BTW, Dr Feldman has a new article on JAMA set for release. Online only for now , 1st page free. Probably out in next issue. Even on the 1st page it addresses that there were varied patients in trials. Meaning, purposely not patients that fit into criteria. They were testing the waters to hone specificity. So, non-responders.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up